Recombinant FOLR1 (Mirvetuximab Biosimilar) antibody

Catalog No. ABIN7795120

This anti-FOLR1 (Mirvetuximab Biosimilar) antibody is a Mouse Monoclonal antibody detecting FOLR1 (Mirvetuximab Biosimilar) in FACS and in vivo. Suitable for Human.

Quick Overview for Recombinant FOLR1 (Mirvetuximab Biosimilar) antibody (ABIN7795120)

Target: FOLR1 (Mirvetuximab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This FOLR1 (Mirvetuximab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS), In vivo Studies (in vivo)

Grade: Research Grade

Product Details anti-FOLR1 (Mirvetuximab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Mirvetuximab Biosimilar, Human FOLR1 Monoclonal Antibody

Characteristics: What is Mirvetuximab biosimilar research grade? Mirvetuximab biosimilar uses the same protein sequences as the therapeutic antibody Mirvetuximab. Mirvetuximab soravtansine is used as a treatment for epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. Mirvetuximab soravtansine is a folate receptor alpha (FRa)-directed antibody and microtubule inhibitor conjugate.

Purification: Protein A or G affinity column

Purity: >95 % by reducing SDS-PAGE

Endotoxin Level: < 1 EU per 1 mg of the protein by the LAL method

Immunogen: Human FOLR1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: > 3 mg/mL

Storage: 4 °C,-20 °C

Storage Comment: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Target Details for FOLR1 (Mirvetuximab Biosimilar)

Target: FOLR1 (Mirvetuximab Biosimilar)

Alternative Name: Mirvetuximab Biosimilar

Target Type: Biosimilar